CFDE Data Portal | Search LMO3

	Label	Description
	LMO3 Gene (Entity type)	ENSG00000048540 - LIM domain only 3
	LMO3 associations Collection (Entity type)	Associations for LMO3_associations
	LMO3 associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	GSE239844 6 V 10 CRIZOTINIB HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE205976 GSE205978 CEP83 knockout TIME 1 v 4 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE239844 crizotinib 1 v 10 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE146687 2 V 5 ERIBULIN HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE233679 5 V 15 NICOTINAMIDE HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE193258,GSE193259 2 V 4 OSIMERTINIB HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE233679 nicotinamide 14 v 15 human up Gene Set (Entity type)	A Gene Set from LINCS

LMO3

ENSG00000048540 - LIM domain only 3

LMO3 associations

Associations for LMO3_associations

LMO3 associations.tsv

A file from IDG as part of the Harmonizome project

GSE239844 6 V 10 CRIZOTINIB HUMAN DN

A Gene Set from LINCS

GSE205976 GSE205978 CEP83 knockout TIME 1 v 4 human dn

A Gene Set from LINCS

GSE239844 crizotinib 1 v 10 human dn

A Gene Set from LINCS

GSE146687 2 V 5 ERIBULIN HUMAN DN

A Gene Set from LINCS

GSE233679 5 V 15 NICOTINAMIDE HUMAN UP

A Gene Set from LINCS

GSE193258,GSE193259 2 V 4 OSIMERTINIB HUMAN DN

A Gene Set from LINCS

GSE233679 nicotinamide 14 v 15 human up

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.